Tender notice
NHS National Generic Pharmaceuticals Wave 13
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS EnglandTender value£710,767,138
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
Tender Close: 26th July 2021, 13:00. Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months)
Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months)
Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)